Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 29 August 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Screening fecal calprotectin in diagnosis of IBD is effective

The latest issue of the Clinical Gastroenterology & Hepatology evaluates the effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of IBD in adults and children.

News image

The level of fecal calprotectin can predict the onset of inflammatory bowel disease (IBD) with high accuracy and precision.

Dr Park and colleagues from California, USA evaluated the cost-effectiveness of using measurements of fecal calprotectin to identify adults and children who require endoscopic confirmation of IBD.

The researchers constructed a decision analytic tree to compare the cost-effectiveness of measuring fecal calprotectin before endoscopy examination with that of direct endoscopic evaluation alone.

A second decision analytic tree was constructed to evaluate the cost-effectiveness of fecal calprotectin cutoff levels of 100 μg/g vs 50 μg/g.

Fecal calprotectin screening saved $417 per patient
Clinical Gastroenterology & Hepatology

The team's primary outcome measure was the incremental cost required to avoid 1 false-negative result by using fecal calprotectin level to diagnose new-onset IBD.

In adults, fecal calprotectin screening saved $417 per patient but delayed diagnosis for 2 out of 32 patients with IBD among 100 screened patients.

In children, fecal calprotectin screening saved $300 per patient but delayed diagnosis for 5 out of 61 patients with IBD among 100 screened patients.

The team observed that if endoscopic biopsy analysis remained the standard for diagnosis, direct endoscopic evaluation would cost an additional $18,955 in adults, and $6250 in children to avoid 1 false-negative result from fecal calprotectin screening.
 
Sensitivity analyses showed that cost-effectiveness of fecal calprotectin screening varied with the sensitivity of the test, and the pre-test probability of IBD in adults and children.

The researchers found that pre-test probabilities for IBD of 75% or less in adults, and 65% or less in children made fecal calprotectin screening cost-effective.

However, it was cost-ineffective if the probabilities were 85% or more and 78% or more in adults and children, respectively.

Compared with the fecal calprotectin cutoff level of 100 μg/g, the cutoff level of 50 μg/g cost an additional $55 and $43 for adults and children, respectively.

However, the team noted that it yielded 2 and 6 additional accurate diagnoses of IBD per 100 screened adults and children, respectively.

Dr Park's team concludes, "Screening adults and children to measure fecal levels of calprotectin is effective and cost-effective in identifying those with IBD on a per-case basis when the pre-test probability is ≤75% for adults and ≤65% for children."

"The utility of the test is greater for adults than children."

"Increasing the fecal calprotectin cutoff level to ≥50 μg/g increases diagnostic accuracy without substantially increasing total cost."

Clin Gastroenterol Hepatol 2014: 12(2):  253-262.e2
24 January 2014

Go to top of page Email this page Email this page to a colleague

 29 August 2016 
Risk factor for post-ERCP pancreatitis
 29 August 2016 
Hep B immunization of infants for liver cancer
 29 August 2016 
Reducing Hep B-related HCC
 26 August 2016 
Celiac disease therapeutics
 26 August 2016 
Reasons for premature surveillance colonoscopy
 26 August 2016 
Bleeding after endoscopic dissection-induced gastric ulcers
 25 August 2016 
Short-chain fatty acids in mixed refractory constipation
 25 August 2016 
Stool DNA test for colorectal cancer screening
 25 August 2016 
Post-infectious IBS in C. diff
 24 August 2016 
Hep B after infant vaccination program
 24 August 2016 
Obeticholic acid for primary biliary cholangitis
 24 August 2016 
Genetics and therapy response in IBD
 23 August 2016 
Colorectal cancer genetics as biomarkers
 23 August 2016 
Prognostic test for mortality after liver transplant
 23 August 2016 
Postoperative mortality in elderly with IBD
 22 August 2016 
Celiac disease in the elderly
 22 August 2016 
Laparoscopic vs open colectomy databases
 22 August 2016 
Mucosal healing and ulcerative colitis outcomes
 19 August 2016 
Dietary questionnaire for GI clinics
 19 August 2016 
Botox treatment for chronic anal fissure
 19 August 2016 
Myeloid-derived suppressor cells in GI cancers
 18 August 2016 
Gallstone formation determinants
 18 August 2016 
Age disparities in IBD therapy
 18 August 2016 
Seasonal variation in diverticulitis
 17 August 2016 
IBD activity score for routine clinical use
 17 August 2016 
Attitudes to H. pylori in primary care
 17 August 2016 
Nonselective β-blockers and mortality in cirrhosis
 16 August 2016 
Upper GI lesions in adults with IBD
 16 August 2016 
C. difficile infection and mortality when managed by GI surgeons
 16 August 2016 
HCV eradication in cirrhosis
 15 August 2016 
Predicting favorable outcomes in IBD
 15 August 2016 
Scoring system predicted microscopic colitis
 15 August 2016 
Mortality in spontaneous bacterial peritonitis
 12 August 2016 
Recurrence of resected gastric cancer
 12 August 2016 
Screening for pancreatic cancer
 12 August 2016 
Index for diagnostic accuracy of Crohn's
 11 August 2016 
Colorectal neoplasm on surveillance colonoscopies
 11 August 2016 
Bowel disease in primary care patients with bowel symptoms
 11 August 2016 
Diagnosis in covert hepatic encephalopathy
 10 August 2016 
Maintenance therapy for children with eosinophilic esophagitis
 10 August 2016 
Moderate alcohol use and insulin action in HCV
 10 August 2016 
Consensus on the management of GERD
 09 August 2016 
Pancreatitis quality of life instrument
 09 August 2016 
Gallstone disease and NAFLD
 09 August 2016 
Steroid dependency and IBD
 08 August 2016 
Venous thromboembolism in celiac disease
 08 August 2016 
C. diff in IBD 
 08 August 2016 
Gut-directed hypnotherapy vs low FODMAP diet in IBS
 05 August 2016 
Therapy for H.pylori treatment
 05 August 2016 
Obesity and the development of NAFLD
 05 August 2016 
Obesity and CVD in celiac disease
 04 August 2016 
Bleeding after endoscopic resection of colorectal lesions
 04 August 2016 
Novel risk factor for post-ERCP pancreatitis
 04 August 2016 
Ondansetron for children with acute gastroenteritis
 03 August 2016 
Post-colonoscopy complications
 03 August 2016 
IVF in women with IBD
 03 August 2016 
Post-operative pancreatic fistulae after pancreatic surgery
 02 August 2016 
H. pylori in children
 02 August 2016 
Gastric cancer in patients with gastric intestinal metaplasia
 02 August 2016 
Behavioral changes and bariatric surgery

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us